Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Gadicke Ansbert
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   30,197    

Indirect Shares

   56,162,356      
Direct Value   $24,046    

Indirect Value

   $178,507,237      
Total Shares   56,192,553      
Total Value   $178,531,282      


Allovir Inc $24,046 Allovir Inc $24,046
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rigel Pharmaceuticals Inc RIGL Former 10% Owner 2004-07-02 0 2004-09-13 475,026    Premium*  
            Idenix Pharmaceuticals Inc IDIX Director, 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Radius Health Inc. RDUS Director 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Former 10% Owner 0 2013-03-11 2,790,479    Premium*  
            Verastem, Inc. VSTM Director 2012-02-01 0 2012-02-01 3,740    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 2012-06-05 0 2012-07-09 1,275,886    Premium*  
            Epizyme, Inc. EPZM 10% Owner 0 2014-02-10 2,413,819    Premium*  
            Aratana Therapeutics, Inc. PETX 10% Owner 2014-03-07 0 2014-03-07 3,388,165    Premium*  
            Chiasma, Inc CHMA Director, 10% Owner 2015-07-21 0 2015-07-21 5,681,544    Premium*  
            Harpoon Therapeutics, Inc. HARP 10% Owner 2019-02-12 0 2019-02-12 8,422,847    Premium*  
            Tcr2 Therapeutics Inc. TCRR Director, 10% Owner 2019-02-19 0 2023-06-01 0    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2021-07-12 3,882,485    Premium*  
            Allovir Inc ALVR Director, 10% Owner 2022-07-28 30,197 2022-07-28 16,674,766    Premium*  
            Dyne Therapeutics, Inc. DYN 10% Owner 2020-09-21 0 2020-09-21 91,081    Premium*  
            Oncorus, Inc. ONCR 10% Owner 0 2020-10-06 2,377,025    Premium*  
* Premium Members only  

Records found :    108         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALVR Allovir Inc Director   –       •       •   2020-07-29 3 IO $0.00 $0 D/D 0 30,197 -
ALVR Allovir Inc Director   –       •       •   2020-08-03 4 A $0.00 $0 I/I 13,420,970 13,420,970 0 -
ALVR Allovir Inc Director   –       •       •   2022-07-28 4 A $4.61 $15,000,000 I/I 3,253,796 16,674,766 0 -
PETX Aratana Therapeutics, Inc... 10% Owner   –       –       •   2014-03-07 4 S $20.16 $538,534 D/D (26,713) 0 0 -
CHMA Chiasma, Inc Director   –       •       •   2015-07-21 4 A $0.00 $0 I/I 5,681,544 5,681,544 0 -
DYN Dyne Therapeutics, Inc. 10% Owner   –       –       •   2020-09-21 4 A $0.00 $0 I/I 4,951,303 91,081 0 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2013-05-30 3 IO $0.00 $0 I/I 0 178,331 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2013-06-05 4 A $0.00 $0 I/I 2,702,154 2,880,485 0 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2014-02-10 4 S $29.25 $13,649,981 I/I (466,666) 2,413,819 0 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2019-02-12 4 B $14.00 $7,000,000 I/I 500,000 8,422,847 1.5 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2019-02-12 4 S $14.00 $27,594 I/I (1,971) 7,922,847 0 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2019-02-12 4 OE $0.05 $27,513 I/I 559,215 7,924,818 0 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2019-02-12 4 A $0.00 $0 I/I 7,043,540 7,365,603 0 -
IDIX Idenix Pharmaceuticals In... Director   –       •       •   2004-07-21 3 IO $0.00 $0 I/I 0 5,306,362 -
IDIX Idenix Pharmaceuticals In... Director   –       •       •   2004-07-27 4 S $14.00 $7,117,194 I/I (508,371) 4,797,991 -
ONCR Oncorus, Inc. 10% Owner   –       –       •   2020-10-01 3 IO $0.00 $0 I/I 0 115,823 -
ONCR Oncorus, Inc. 10% Owner   –       –       •   2020-10-06 4 B $15.00 $4,875,000 I/I 325,000 2,377,025 1.5 -
ONCR Oncorus, Inc. 10% Owner   –       –       •   2020-10-06 4 A $0.00 $0 I/I 4,785,655 2,225,801 0 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-02-02 3 IO $0.00 $0 I/I 0 92,980 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-02-08 4/A A $0.00 $0 I/I 2,200,247 2,293,227 0 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-02-08 4/A B $7.00 $3,749,998 I/I 535,714 2,828,941 1.5 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-11-21 4 B $6.50 $2,999,997 I/I 461,538 3,290,479 1.5 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2012-02-08 4 B $7.00 $3,749,998 I/I 535,714 2,828,941 1.5 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2012-02-08 4 A $0.00 $0 I/I 2,200,247 2,293,227 0 -
PCRX Pacira Pharmaceuticals, I... Former 10% Owner   –       –      –    2013-03-11 4 S $27.86 $13,930,000 I/I (500,000) 2,790,479 0 -
  108  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us